The objective of this thesis is to provide a reliable and effective iron loss estimation scheme for the electromagnetic steel products in the design and on-line operation stages. To investigate the possible performance of electromagnetic steel products, proper iron loss information of the products that are constructed by different steels is one of the key concerns. Along with the various power electronic device applications and iron core structures, the magnetic fluxes flowing through the machine cores will be non-uniform and include harmonic terms. Unless excessive computation efforts in expensive software tools are performed, large discrepancies will be exhibited the estimated and actual values of machine iron losses. To overcome these drawbacks, a rational machine iron loss estimation scheme is proposed. By adopting the iterative magnetic equivalent circuits and the nonlinear magnetic characteristics of the electromagnetic steels, the preliminary operational flux information in the machine is first obtained, and then a numerical Epstein Frame test circuit with magnetizing inductance modeled by Preisach model is applied. With appropriate circuit input voltages devised from preliminary information, the detailed hysteresis inner-loop characteristics resulting from product structures and magnetization harmonics can be properly modeled. Based on the circuit results, the iron losses of electric machines with any operation can be rationally evaluated, and a valuable reference in machine designing can be provided.

Diss. (sammanfattning) Göteborg : Göteborgs universitet, 2009. / Härtill 3 uppsatser.

Epstein-Barr virus (EBV) is one of the most successful human pathogens in the world and establishes a lifelong persistent infection in 95% of adult population worldwide. It is associated with a number of malignancies including Burkett’s lymphoma, Hodgkin’s lymphoma, nasopharyngeal carcinoma(NPC) and gastric carcinoma. EBV was the first virus reported to produce microRNAs (miRNAs) and it encodes 44 mature miRNAs from 2 viral transcripts, BART and BHRF1. The BART transcript is abundantly expressed in all latently infected cells, particularly in epithelial cells. The BART miRNAs (miR-BARTs) were shown to be involved in apoptosis inhibition, immune evasion, metastasis, viral and cellular transcripts regulation. The high expression profile and the diverse functions of miR-BARTs suggest that they may play a critical role in the development of EBV-associated NPC. In order to understand the importance of miR-BARTs in NPC development, in this thesis, I conducted a study on the miR-BARTs function in nasopharyngeal carcinogenesis. In the first part, I characterized the cellular target and function of an abundantly expressed miR-BART in NPC. In the second part, I established a novel recombinant EBV construction system for genetic studies of miR-BARTs in nasopharyngeal epithelial (NP) cells. In the first part of my study, I characterized the cellular target and function of miR-BART3* in NPC. As predicted by bioinformatics, tumor suppressor protein DICE1 was a cellular target of miR-BART3*. The specific targeting between miR-BART3* and DICE1 3’UTR was validated by luciferase assays and the downregulation of both endogenous DICE1 protein and mRNA was observed in EBV+epithelial cells and miR-BART3* expressing cells. In addition, restoration of DICE1 protein expression by inhibition of miR-BART3* was also demonstrated in EBV+epithelial cells. Moreover, miR-BART3* was shown to promote cell proliferation via suppression of DICE1. Analysis of22 human nasopharyngeal(NP)biopsy samples demonstrated the inverse correlation between miR-BART3* and DICE1 expression. Taken together, miR-BART3* downregulates the tumor suppressor DICE1 protein to promote cell proliferation and transformation in NPC. Besides the candidate approach, genetic studies can provide a systematic view of the functions of all miR-BARTsand shed light on the importance of miR-BARTs in NPC under a more physiological condition. At present, bacterial artificial chromosome (BAC) technology is commonly used for recombinant EBV construction. However, the intrinsic disadvantages of BAC prevent its use in NP epithelial cells. Therefore in the second part of my study, I established a novel CRISPR/Cas9-mediated recombinant EBV construction system and constructed a miR-BART deleted recombinant EBV. The CRISPR/Cas9 system was demonstrated to be effective in EBV genome editing and Akata cells were infected by the recovered recombinant mutant virus. Infected Akata cells served as the source for NP cell infection through co-culture. The new CRISPR/Cas9 system have many advantages over the conventional EBV BAC method. My work reported in this thesis not only illustrated the importance of miR-BARTs in NPC, but also provide a new technology platform for further study of miR-BARTs in NP epithelial cells. (An / published_or_final_version / Biochemistry / Doctoral / Doctor of Philosophy

Burkitt lymphoma (BL) was the first tumor found to be strongly associated with Epstein-Barr virus (EBV). Almost 100% of the lymphoma cells are cycling, necessitating dose- and time-intense multi-agent chemotherapy regimens to achieve a cure of the disease. Whilst standard risk BL can be cured with this approach, high risk BL with leukaemic and CNS disease has significantly inferior survival. The intensive chemotherapy regimen causes considerable toxicity to the patients and relapse of BL is largely incurable. Thus, novel therapeutic approaches for high risk and relapsed BL are needed. Histone deacetylase inhibitors (HDACis) represent a novel class of drugs with potent anti-cancer effect in a wide range of malignancies. In the first part of this study, we tested HDACis of different classes for their ability to inhibit cell proliferation and activate the lytic cycle of EBV in a panel of EBV-positive BL cells of different latent viral gene expression patterns (type I, Wp-restricted and type III latency with highly restrictive, partial and full spectrum of EBV latent gene expression, respectively). Different HDACis could inhibit proliferation of EBV-positive BL cells in a time- and dose-dependent manner but only weakly activate the viral lytic cycle indicating that the drugs’ cytotoxic effect is independent of the EBV lytic cycle. Of note, BL cells of Wp-restricted or type III latency were more resistant to killing by HDACis than those of latency I, suggesting a possible link between relative resistance to the drug and expression of the latent viral genes. Bortezomib, a proteasome inhibitor, may have synergistic action with HDACis on lymphoid malignancies. We hypothesized that Bortezomib could potentiate the killing of EBV-positive BL cells by HDACis. In the second part, we tested the effect of combination of a FDA-approved HDACi, suberoylanilide hydroxamic acid (SAHA) and Bortezomib in the same panel of BL cells and also EBV-transformed lymphoblastoid cell lines (LCLs) which represent an in-vitro model of EBV-associated post-transplant lymphoproliferative disorder (PTLD). Interestingly, combination of SAHA and Bortezomib significantly enhanced the killing of BL cells of Wp-restricted or type III latency. Furthermore, the resistance to either SAHA or Bortezomib alone in contrast to synergistic killing by the combination of the two drugs could be observed in LCLs which also have the type III latency pattern. Compared with either drug alone, combination of SAHA and Bortezomib induced enhanced apoptosis in Wp-restricetd BL cells and LCLs as shown by the increase in the percentage of annexin V-positive cell, sub-G1 population and the proteolytic cleavage of apoptotic markers including PARP, caspase-3 and -9. The drug combination hyper-acetylated histone and induced cell cycle arrest. Combination of SAHA and Bortezomib was further shown to suppress the growth of BL xenograft in nude mice. In conclusion, our data indicated that expression of partial or full spectrum of viral latent genes in EBV-positive BL cells of Wp-restricted or type III latency confers resistance of the tumor cells to cytotoxic effect of HDACis. Bortezomib could potentiate SAHA-induced apoptosis of both BL cells and LCLs and might overcome mechanism of drug resistance. / published_or_final_version / Paediatrics and Adolescent Medicine / Master / Master of Philosophy

<p>Epstein-Barr virus (EBV) is a ubiquitous human gamma-herpesvirus which chronically infects >95% of the global population, and can give rise to a number of malignancies in B cells and epithelial cells. In EBV latently infected epithelial cells, such as nasopharyngeal carcinoma (NPC) and gastric carcinoma (GaCa) cells, viral protein expression is low. In contrast, a cluster of viral microRNAs (miRNAs) called miR-BARTs is highly expressed. MiRNAs are small non-coding RNAs which regulate gene expression by binding to complementary sequences in mRNAs. It is likely that miR-BARTs play a crucial role in EBV-infected epithelial cells, however a comprehensive understanding of miR-BARTs is currently lacking. Here, I present two studies utilizing the phenotypic and the target approaches, respectively, to demonstrate that miR-BARTs can inhibit apoptosis and activate the Wnt signaling pathway. To discover miR-BARTs that can inhibit apoptosis, I individually expressed miR-BARTs in the EBV- GaCa cell line AGS, and identified five miR-BARTs that conferred this phenotype. To identify pro-apoptotic genes targeted by the five anti-apoptotic miRNAs, I validated one previously published target and identified nine novel targets by performing photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) in the EBV+ NPC cell line C666. Next, I thoroughly demonstrated that the 10 candidate target genes were substantially suppressed by expression of the relevant miR-BARTs, as measured by 3’UTR-containing firefly luciferase (FLuc) expression, mRNA and protein levels, and knockdown of seven of the 10 candidate genes could suppress apoptosis, mimicking the effects of relevant miR-BARTs. On the other hand, in order to identify miR-BARTs that can activate the Wnt signaling pathway, I analyzed the PAR-CLIP data set of C666 cells and discovered nine anti-Wnt signaling targets of miR-BARTs, including seven novel genes and two pro-apoptotic genes identified above. Using FLuc 3’UTR indicator assays, I proved that the 3’UTRs of all seven newly identified anti-Wnt signaling genes were indeed targeted by the relevant miR-BARTs identified by PAR-CLIP. Utilizing a Wnt signaling FLuc reporter TOPflash which measures the Wnt signaling activation, I confirmed that expression of many miR-BARTs that target Wnt signaling inhibitors can indeed upregulate the Wnt signaling pathway. Together, my results identified and validated a substantial number of novel targets of miR-BARTs involved in apoptosis and the Wnt signaling pathway, indicating that EBV may employ miR-BARTs to heavily target these two pathways to facilitate chronic infection.</p> / Dissertation

published_or_final_version / Medical Sciences / Master / Master of Medical Sciences

published_or_final_version / Microbiology / Master / Master of Philosophy

Στην παρούσα μελέτη διερευνάται το ζήτημα της συνεργασίας σχολείου και οικογένειας, όπως αυτό παρουσιάζεται από την πλευρά τον γονέων. Πιο συγκεκριμένα εξετάζονται οι αντιλήψεις των γονέων για το ζήτημα της συνεργασίας, το πως οι ίδιοι συνεργάζονται και συμμετέχουν στην τάξη με το νηπιαγωγό και τα παιδιά, τη συχνότητα που αυτή έχει, πιθανά προβλήματα που ίσως έχουν αντιμετωπίσει στη συνεργασία μαζί τους καθώς και το ποια είναι η ιδανική συνεργασία για τους ίδιους. Πέρα από τη συναφή βιβλιογραφία, η έρευνα στηρίζεται και σε ατομικές, σε βάθος συνεντεύξεις με τους γονείς. Τα ευρήματα που προέκυψαν από την εργασία είναι πως όλοι θεωρούν σημαντική τη συνεργασία με τους νηπιαγωγούς αλλά σχεδόν κανείς δε συνεργάζεται αρκετά. Οι συναντήσεις γίνονται κυρίως σε προσωπικό επίπεδο και πάντα στο χώρο του σχολείου. Μιλούν σχεδόν πάντα για την επίδοση και τη συμπεριφορά του παιδιού στη τάξη καθώς και για ενδεχόμενα γνωστικά προβλήματα ή προβλήματα συμπεριφοράς που μπορεί να παρουσιαστούν. / This study investigates the issue of cooperation between school and family, as this is pictured in parent’s side. More specifically, discussed the perceptions of parents on the cause of collaboration, how they associate with the teacher of their child and also in which way they take part in the proceedings of the class not only with her but also with the children too. Moreover, we are looking for the frequency of the cooperation, possible problems that they may have dealt with and finally which is the ideal cooperation for them with the educators. Apart from the relevant bibliography, survey is based in individual and in detail interviews with parents. The data resulted from the project indicate that all parents regard, the cooperation with kindergarten, as very important but almost none of them cooperate fairly. Meetings are held primarily on a personal level and always at the school. They talk about the child’s progress and his or her behavior in class and some cognitive and behavioral problems that may occur.

<p>The interaction of human tumor viruses with host growth suppressive pathways is a fine balance between controlled latent infection and virus-induced oncogenesis. This dissertation elucidates how Epstein-Barr virus interacts with the host growth suppressive DNA damage response signaling pathways (DDR) in order to transform infected human B lymphocytes. </p><p> Here I report that the activation of the ATM/Chk2 branch of the DDR in hyper-proliferating infected B cells results in G1/S cell cycle arrest and limits viral-mediated transformation. Similar growth arrest was found in mitogen-driven proliferating of B cells that sets the DDR as a default growth suppressive mechanism in human B cells. Hence, the viral protein EBNA3C functions to attenuate the host DDR and to promote immortalization of a small portion of infected B cells. Additionally, the pharmacological inhibition of the DDR in vitro increases viral immortalization of memory B cells that facilitates the isolation of broadly neutralizing antibodies to various infectious agents. Overall, this work defines early EBV-infected hyper-proliferating B cells as a new stage in viral infection that determines subsequent viral-mediated tumorigenesis.</p> / Dissertation

The Epstein-Barr virus (EBV) protein, Latent Membrane Protein 2A (LMP2A), is critical for maintaining viral latency and provides pro-survival and pro-migratory signals to EBV-positive B and epithelial cell malignancies. The N-terminus of LMP2A contains several protein-protein interaction motifs involved in the recruitment of cellular signalling proteins and it is through the recruitment of these proteins that LMP2A is able to initiate signalling. In B lymphocytes, LMP2A's ability to initiate signalling was originally proposed to proceed via a two step mechanism. Firstly, recruitment of the Lyn tyrosine kinase to the tyrosine phosphorylated YEEA site in LMP2A allows for tyrosine phosphorylation of the LMP2A immunoreceptor tyrosine-based activation motif (ITAM). This, in turn, facilitates the recruitment and activation of Syk tyrosine kinase which then initiates downstream signalling events. However, recent findings suggest this model may not be correct and argue that Syk recruitment to LMP2A is independent of the YEEA site. Therefore, we undertook a series of experiments to better understand the role of the YEEA motif and Lyn in the initiation of LMP2A signalling in B lymphocytes. We found that the YEEA site was not absolutely required for tyrosine phosphorylation of the LMP2A ITAM, or for LMP2A to activate Syk. Using siRNA to silence Lyn expression in LCLs. we found that reducing Lyn expression inhibited the ability of LMP2A to promote Syk tyrosine phosphorylation. In contrast, DG75 B cells or Lyn-deficient DT40 B cells transiently expressing higher levels of LMP2A did not require Lyn for LMP2A-mediated Syk phosphorylation. Furthermore, Lyn was not required for LMP2A-mediated Akt activation in DG75 B cells, but rather Akt activation was significantly enhanced in LMP2A-expressing cells where Lyn was reduced by siRNA. We propose that Lyn negatively regulates LMP2A-mediated Akt activation by phosphorylating Syk on Y323, which serves to recruit the c-Cbl E3 ubiquitin ligase to Syk and targets Syk for ubiquitin-mediated degradation. In sum, this work provides novel insight into how LMP2A uses Lyn to initiate and titre signalling in B cells and brings to light an unappreciated role for Lyn as a negative regulator of LMP2A-mediated Akt activation.